Bradshaw M, Rutherford M S, Hoeper B J, McWhinney C D, Borcherding D R, Schook L B, Edwards C K
Department of Animal Sciences, University of Illinois at Urbana-Champaign, USA.
J Pharmacol Exp Ther. 1995 Jun;273(3):1506-18.
Tumor necrosis factor-alpha (TNF-alpha) is a powerful macrophage-derived proinflammatory cytokine, via both direct effects on host tissues as well as indirectly through the induction of other proinflammatory mediators, including interleukin- (IL) 1 beta and IL-6. Activation of murine bone marrow-derived macrophages (BMDM phi) with lipopolysaccharide (LPS) causes rapid expression of TNF-alpha, which as an autocrine factor enhances BMDM phi function through IL-1 beta and IL-6 production. In this study, we have examined the specific transcriptional inhibition of BMDM phi TNF-alpha using novel enantiomeric carbocyclic nucleoside analogues. BMDM phi were derived in vitro from murine bone marrow progenitors using colony stimulating factor-1 and treated with combinations of LPS (1-100 nG/ml) and the enantiomeric carbocyclic nucleoside (10-100 microM) analogues MDL 201, 112 (9-[(1S,3R)-cis-cyclopentan-3-ol]adenine); MDL 201,451 (9-[1R,3S)-cis-cyclopentan-3-ol]adenine); MDL 201,449 (9-[(1R,3R)-trans-cyclopentan-3-ol]adenine) and MDL 201,484 (9-[(1S,3S)-trans-cyclopentan-3-ol]adenine). Northern blot analysis showed that MDL 201,449 was the most effective agent in vitro at selectively inhibiting TNF-alpha. MDL 201,449 reduced TNF-alpha mRNA levels by nearly 50% for up to 4 hr after the simultaneous addition of LPS and the synthetic agent. In contrast, mRNA and secreted protein levels for IL-1 beta (measured by the D10.S bioassay) and mRNA for TNF-alpha receptor p60 and TNF-alpha receptor p80 were not significantly affected. Carbocyclic nucleoside analogues were effective when added to BMDM phi up-to 2 hr after LPS treatment and at concentrations as low as 10 microM. Regulation of BMDM phi IL-6 by carbocyclic nucleoside analogues in response to LPS appears to be both concentration and time dependent, because IL-6 mRNA and secreted protein levels were inhibited at only high drug concentrations (100 microM) and effective only at longer exposure times (+4 hr of incubation) to LPS. These data support the concept that M phi-derived proinflammatory cytokine gene expression is differentially, rather than coordinately, regulated by selective signal transduction and/or molecular pathways. Enantiomeric carbocyclic nucleoside analogues that specifically inhibit TNF-alpha may have therapeutic potential in inflammatory diseases, such as systemic inflammatory response syndrome, where TNF-alpha has been shown to have an important role in initiating the early stages of disease.
肿瘤坏死因子-α(TNF-α)是一种由巨噬细胞产生的强大促炎细胞因子,它可直接作用于宿主组织,也可通过诱导其他促炎介质(包括白细胞介素-1β和白细胞介素-6)间接发挥作用。用脂多糖(LPS)激活小鼠骨髓来源的巨噬细胞(BMDMφ)会导致TNF-α快速表达,TNF-α作为一种自分泌因子,通过产生白细胞介素-1β和白细胞介素-6来增强BMDMφ的功能。在本研究中,我们使用新型对映体碳环核苷类似物研究了对BMDMφ TNF-α的特异性转录抑制作用。BMDMφ是在体外使用集落刺激因子-1从小鼠骨髓祖细胞中获得的,并分别用LPS(1-100 ng/ml)和对映体碳环核苷(10-100 μM)类似物MDL 201,112(9-[(1S,3R)-顺式-环戊烷-3-醇]腺嘌呤)、MDL 201,451(9-[1R,3S)-顺式-环戊烷-3-醇]腺嘌呤)、MDL 201,449(9-[(1R,3R)-反式-环戊烷-3-醇]腺嘌呤)和MDL 201,484(9-[(1S,3S)-反式-环戊烷-3-醇]腺嘌呤)进行处理。Northern印迹分析表明,MDL 201,449是体外选择性抑制TNF-α最有效的药物。在同时加入LPS和该合成药物后长达4小时内,MDL 201,449可使TNF-α mRNA水平降低近50%。相比之下,白细胞介素-1β的mRNA和分泌蛋白水平(通过D10.S生物测定法测量)以及TNF-α受体p60和TNF-α受体p80的mRNA水平均未受到显著影响。碳环核苷类似物在LPS处理后长达2小时添加到BMDMφ中时有效,且浓度低至10 μM。碳环核苷类似物对LPS刺激的BMDMφ白细胞介素-6的调节似乎既依赖浓度又依赖时间,因为白细胞介素-6的mRNA和分泌蛋白水平仅在高药物浓度(100 μM)下受到抑制,且仅在较长暴露时间(孵育4小时)时对LPS有效。这些数据支持这样一种观点,即巨噬细胞衍生的促炎细胞因子基因表达是通过选择性信号转导和/或分子途径进行差异调节,而非协同调节。特异性抑制TNF-α的对映体碳环核苷类似物在炎症性疾病(如全身炎症反应综合征)中可能具有治疗潜力,在该疾病中,TNF-α已被证明在疾病早期阶段起重要作用。